Ding Ma

Dr. Ding Ma


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2020 in Journal of Hematology & Oncology
Verified
Journal Article
Open access
PDF file
YMYifan Meng
Yifan Meng
WLWanrong Lu
Wanrong Lu
EGEnsong Guo
Ensong Guo
JLJia Liu
Jia Liu
BYBin Yang
Bin Yang
GCGang Chen
Gang Chen
Background: Although research on the effects of comorbidities on coronavirus disease 2019 (COVID-19) patients is increasing, the risk of cancer history has not been evaluated for the mortality of patients with COVID-19. Methods: In this retrospective study, we included 3232 patients with pathogen-confirmed COVID-19 who were hospitalized between January 18th and March 27th, 2020, at Tongji Hospital in Wuhan, China. Propensity score matching was used to minimize selection bias. Results: In total, 2665 patients with complete clinical outcomes were analyzed. The impacts of age, sex, and comorbidities were evaluated separately using binary logistic regression analysis. The results showed that age, sex, and cancer history are independent risk factors for mortality in hospitalized COVID-19 patients. COVID-19 patients with cancer exhibited a significant increase in mortality rate (29.4% vs. 10.2%, P < 0.0001). Furthermore, the clinical outcomes of patients with hematological malignancies were worse, with a mortality rate twice that of patients with solid tumors (50% vs. 26.1%). Importantly, cancer patients with complications had a significantly higher risk of poor outcomes. One hundred nine cancer patients were matched to noncancer controls in a 1:3 ratio by propensity score matching. After propensity score matching, the cancer patients still had a higher risk of mortality than the matched noncancer patients (odds ratio (OR) 2.98, 95% confidence interval (95% CI) 1.76–5.06). Additionally, elevations in ferritin, high-sensitivity C-reactive protein, erythrocyte sedimentation rate, procalcitonin, prothrombin time, interleukin-2 (IL-2) receptor, and interleukin-6 (IL-6) were observed in cancer patients. Conclusions: We evaluated prognostic factors with epidemiological analysis and highlighted a higher risk of mortality for cancer patients with COVID-19. Importantly, cancer history was the only independent risk factor for COVID-19 among common comorbidities, while other comorbidities may act through other factors. Moreover, several laboratory parameters were significantly different between cancer patients and matched noncancer patients, which may indicate specific immune and inflammatory reactions in COVID-19 patients with cancer.

27 July 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
PWPeng Wu
Peng Wu
DCDongsheng Chen
Dongsheng Chen
WDWencheng Ding
Wencheng Ding
PWPing Wu
Ping Wu
HHHongyan Hou
Hongyan Hou
GCGang Chen
Gang Chen
The outbreak of coronavirus disease 2019 (COVID-19) is a global health emergency. Various omics results have been reported for COVID-19, but the molecular hallmarks of COVID-19, especially in those patients without comorbidities, have not been fully investigated. Here we collect blood samples from 231 COVID-19 patients, prefiltered to exclude those with selected comorbidities, yet with symptoms ranging from asymptomatic to critically ill. Using integrative analysis of genomic, transcriptomic, proteomic, metabolomic and lipidomic profiles, we report a trans-omics landscape for COVID-19. Our analyses find neutrophils heterogeneity between asymptomatic and critically ill patients. Meanwhile, neutrophils over-activation, arginine depletion and tryptophan metabolites accumulation correlate with T cell dysfunction in critical patients. Our multi-omics data and characterization of peripheral blood from COVID-19 patients may thus help provide clues regarding pathophysiology of and potential therapeutic strategies for COVID-19.

19 August 2014 in Nature Communications
Verified
Journal Article
Open access
PDF file
KCKexin Chen
Kexin Chen
HMHongxia Ma
Hongxia Ma
LLLian Li
Lian Li
RZRongyu Zang
Rongyu Zang
CWCheng Wang
Cheng Wang
QWQingyi Wei
Qingyi Wei
Ovarian cancer is the leading cause of death from gynaecological malignancies worldwide. Here we perform a three-stage genome-wide association study (GWAS) in Han Chinese women to identify risk genetic variants for epithelial ovarian cancer (EOC). We scan 900,015 single-nucleotide polymorphisms (SNPs) in 1,057 EOC cases and 1,191 controls in stage I, and replicate 41 SNPs (Pmeta<10−4) in 960 EOC cases and 1,799 controls (stage II), and an additional 492 EOC cases and 1,004 controls (stage III). Finally, we identify two EOC susceptibility loci at 9q22.33 (rs1413299 in COL15A1, Pmeta=1.88 × 10−8) and 10p11.21 (rs1192691 near ANKRD30A, Pmeta=2.62 × 10−8), and two consistently replicated loci at 12q14.2 (rs11175194 in SRGAP1, Pmeta=1.14 × 10−7) and 9q34.2 (rs633862 near ABO and SURF6, Pmeta=8.57 × 10−7) (P<0.05 in all three stages). These results may advance our understanding of genetic susceptibility to EOC.

1 April 2021 in Annals of Internal Medicine
Verified
Journal Article
Open access
YFYu Fu
Yu Fu
YLYongsheng Li
Yongsheng Li
EGEnsong Guo
Ensong Guo
LHLiang He
Liang He
JLJia Liu
Jia Liu
GCGang Chen
Gang Chen
Knowledge is limited about the patterns of viral persistence and host response in patients with COVID-19. This large study from Wuhan, China, reports longitudinal data on viral positivity as well t... Background: The understanding of viral positivity and seroconversion during the course of coronavirus disease 2019 (COVID-19) is limited. Objective: To describe patterns of viral polymerase chain r...

26 November 2024 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
HXHongwen Xu
Hongwen Xu
CDChunlin Dong
Chunlin Dong
TXTongyue Xiang
Tongyue Xiang
XSXianzhong Shentu
Xianzhong Shentu
ZYZhilong Yu
Zhilong Yu
YXYunfei Xie
Yunfei Xie

27 September 2024 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
CDChunlin Dong
Chunlin Dong
HXHongwen Xu
Hongwen Xu
YLYaying Lin
Yaying Lin
BZBing Zhang
Bing Zhang
ZYZhilong Yu
Zhilong Yu
DMDing Ma
Ding Ma
Microplastics (MPs) are synthetic solid particles or polymer matrices that range in size from 1 μm to 5 mm. MPs are widely present in the global biosphere, leading to increasing concerns about their impact on human health. In this study, micro-Raman spectroscopy was used to evaluate the presence and characteristic of MPs in adenomyosis, ovarian ectopic cysts, and uterine tube tissue samples from 60 females. MPs were detected in all human samples at an average level of 1.5 ± 1.2 particles per g of tissue (Average 1.40 ± 1.11 particles per g of tissue after blank correction.). Among these MPs, a total of 11 polymer types were identified. MPs are mainly composed of polyethylene (PE, 31 %), polypropylene (PP, 22 %) and PE-co-PP (11 %). These MPs had an average length of 15.15 ± 6.45 μm and an average width of 12.56 ± 6.65 μm, with the majority (70 %) measuring less than 20 μm in size. Most MPs were fibers (38.9 %) and fragments (24.4 %). A significant correlation (p <0.05) was found between the sizes of MPs detected across the three disease samples, with PE and PP being the most frequently identified types. This study demonstrates the presence of MPs in diseased tissues from patients with adenomyosis, ovarian ectopic cysts, and uterine tubes, providing evidence for the presence of MPs in reproductive system tissues.